Troxipide (the active ingredient) – a drug belonging to the class of peroxisome proliferator-activated receptor (PPAR) alpha agonists.Specific inactive ingredients may vary depending on the formulation (tablet, capsule, etc.) and manufacturer. Always check the product label for a complete list of ingredients.
Hyperlipidemia (high levels of lipids in the blood)
Management of hypertriglyceridemia (high levels of triglycerides in the blood)
In combination with other therapies for managing certain types of cardiovascular disease (Consult your doctor).
Troxpro 100mg Tab (Troxipide) primarily works by activating PPAR-alpha receptors. This leads to an increase in lipoprotein lipase activity, promoting the breakdown of triglycerides. It also affects lipid metabolism, leading to a reduction in serum triglycerides and sometimes improvements in HDL ('good') cholesterol levels. The exact mechanisms are complex and involve multiple pathways within the body's lipid and glucose metabolism.
Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children. Discard any medication that is outdated or shows signs of deterioration.
Dosage and frequency are determined by a doctor based on individual patient needs and response to treatment.
Always follow your doctor's prescription instructions precisely.
Do not stop taking the medication abruptly without consulting your doctor.
Medication may be taken with or without food, as instructed by your physician.
Gastrointestinal disturbances (e.g., nausea, diarrhea, abdominal pain)
Headache
Dizziness
Fatigue
Allergic reactions (rash, itching, swelling)
Elevated liver enzymes (rare, requires monitoring)
The effect of alcohol consumption on the efficacy or safety of Troxipide is not well established, however, it is advisable to avoid excessive alcohol intake while on any medication.
Troxipide may cause dizziness or drowsiness in some individuals. Avoid driving or operating machinery if these side effects are experienced.
The use of Troxipide during pregnancy or breastfeeding is generally not recommended unless specifically prescribed by a doctor due to lack of sufficient safety data. A risk-benefit assessment must be conducted.
Safety and efficacy in children have not been fully established. It is generally not used in children.
Caution is advised in patients with impaired kidney function. Dosage adjustments may be necessary.
Monitor liver function periodically, especially in patients with pre-existing liver conditions, as Troxipide may potentially affect liver enzymes.
Please consult your doctor or pharmacist for detailed information and references specific to your country and available formulations of Troxipide.
